Therefore, cancer-derived extracellular vesicles have gained increasing attention as cancer biomarkers and therapeutic targets.
因此,肿瘤来源的胞外膜泡作为一种新的肿瘤标记物和治疗靶点得到越来越多的关注。
The study was recently published in Cancer Epidemiology, Biomarkers & Prevention.
该研究最近发表在杂志《癌症流行病学,生物标记与预防》上。
Hepatology Digest: Due to the lack of good biomarkers does alpha-fetoprotein have any utility in terms of detecting those who have higher risk of liver cancer?
《国际肝病》:由于缺乏好的生物学标志物,甲胎蛋白在检出那些具有肝癌较高风险的患者方面有效用吗?
The study appears in the September issue of the journal Cancer Epidemiology Biomarkers & Prevention.
这项研究在《癌症流行病学生物标记和预防》杂志第九期中发表。
Promising new imaging techniques and blood tests for biomarkers that would reveal cancer are in the works, they said.
他们说,新的颇具前途的成像技术和生物标记物血液检测均在研究当中。
Potentially, it also could target known biomarkers for a wide variety of diseases, including HIV, cancer and Creutzfeldt-Jakob disease, a degenerative neurological disorder.
它也许还可以为多种疾病锁定已知的生物标记,这些标记包括HIV、癌症、克雅氏病- - -一种退化性神经错乱。
Although exosome biomarkers for diagnosis or prognosis seem to be on the fast track for translational application, both cancer diagnosis and therapy based by exosomes have bright perspectives.
虽然外泌体作为生物标志物用于诊断或预后在转化应用上推进很快,但基于外泌体的癌症诊断和治疗两方面都有很好的前景。
The researchers, writing today in the journal Cancer Epidemiology, Biomarkers & Prevention, tracked about 3,000 women in Shanghai, about half of whom were diagnosed with breast cancer.
今日在《癌症流行病学、生物标记和预防》杂志上撰文的研究人员追踪了上海3,000名妇女,其中约一半的人被诊断患有乳腺癌。
New tools using biomarkers for lung cancer screening are still in research phase and await prospective trials to evaluate their effectiveness.
利用生物标志物进行肺癌的筛查仍处于研究阶段,尚需前瞻性的研究对其效果进行评价。
CONCLUSION: High sensitivity and specificity achieved by this method show great potential for early diagnosis of breast cancer, and screening for new tumor biomarkers.
结论:该方法具有较高的灵敏度和特异度,可用于乳腺癌早期诊断与肿瘤标志物筛选研究。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
目的:评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性,并探索标志物反应。
Oncologists could use these biomarkers to find out if a treatment is working or if surgery has missed some cancer cells, says Velculescu.
Velculescu表示,肿瘤学家可以使用这些生物标记,验证治疗的有效性或是否在手术中落下了一些癌细胞。
Objective to investigate some specific fluorescent substances in gastric juice from patients with gastric carcinoma and to establish biomarkers for the detection of gastric cancer.
目的从胃癌患者胃液中发现特异性荧光物质,并以此来获得肿瘤标志物。
Objective: to establish a lung cancer phage-peptide library and to screen for biomarkers for early detection of lung cancer.
目的:构建肺癌噬菌体展示肽库,筛选出肺癌早期检测的分子标志群。
At present, the company has registered and has on biomarkers for cancer detection and validation of two diagnostic indicators used biomarker patent.
目前,公司已注册并拥有关于生物标志检测技术和验证癌症指标用的两个诊断生物标志专利。
AIM: To screen the potential protein biomarkers in serum for the diagnosis of colorectal cancer (CRC) by the technique of proteomic fingerprint.
目的:探讨蛋白指纹图谱技术筛选大肠癌(CRC)患者血清中可用于诊断的特异性标志物。
Conclusions: SELDI-TOF-MS shows great potentiality for breast cancer in early diagnosis and screening of tumor biomarkers, and deserves generalization.
结论:SELDI- TOF - MS技术对乳腺癌早期诊断和特异性肿瘤标记物的筛选等方面具有一定价值,值得推广。
The method promises to facilitate progress in proteomic studies, especially in the progression of cancer, and may also provide a detailed method for the detection of biomarkers.
这种能检测蛋白质结构变化的特征可以为研究癌症发生的机理和诊断、细胞过程诸如细胞的老化、生长、对环境的损害或中毒性休克反应提供重要的方向。
Hepatology Digest: in terms of biomarkers we are still struggling to find specific candidates for this cancer.
《国际肝病》:就生物学标志物而言,我们仍在努力发现候选的特异性肝癌标志物。
We reviewed the advances of molecular cancer eipdemiology and biomarkers of cancer susceptibility gene. The chances and challenge of molecular cancer eipdemiology research were also discussed.
综述了肿瘤分子流行病学和肿瘤易感基因生物学标志的研究现状,并展望了肿瘤分子流行病学研究的机遇和挑战。
We reviewed the advances of molecular cancer eipdemiology and biomarkers of cancer susceptibility gene. The chances and challenge of molecular cancer eipdemiology research were also discussed.
综述了肿瘤分子流行病学和肿瘤易感基因生物学标志的研究现状,并展望了肿瘤分子流行病学研究的机遇和挑战。
应用推荐